Carbapenemase-producing Enterobacterales infections in COVID-19 patients

References

• Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71:2459–2468.
   PubMed Web of Science ®Google Scholar
• Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275.
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybhardan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26:1622–1629.
   PubMed Web of Science ®Google Scholar
• Clancy CJ, Nguyen MH. COVID-19, superinfections and antimicrobial development: what can we expect? Clin Infect Dis. 2020;71:2736–2743.
   PubMed Web of Science ®Google Scholar
• Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53:505–512.
   PubMedGoogle Scholar
• Dona D, Chiara Sharland DC. M. Multidrug resistant infections in the COVID-19 era, a framework for considering the potential impact. J Hosp Infect. 2020;106:198–199.
   PubMed Web of Science ®Google Scholar
• Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and candida. Ann Intern Med. 2002;136(11):834–844.
   PubMed Web of Science ®Google Scholar
• Paño-Pardo JR, Serrano S, Ramos J, et al. Infections caused by carbapenemase-producing enterobacteriaceae: risk factors, clinical features and prognosis. Enferm Infecc Microbiol Clin. 2014;32(4):41–48.
   PubMedGoogle Scholar
• Martin A, Fahrbach K, Zhao Q, et al. Association between carbapenem resistance and mortality among adult, hospitalized patients with serious infections due to enterobacteriaceae: results of a systematic literature review and Meta-analysis. Open Forum Infect Dis. 2018;5:ofy150.
   PubMed Web of Science ®Google Scholar
• Oteo J, Miró E, Pérez-Vázquez M, et al. Evolution of carbapenemase-producing enterobacteriaceae at the global and national level: what should be expected in the future? Enferm Infecc Microbiol Clin. 2014;32(4):17–23.
   PubMedGoogle Scholar
• Palacios-Baena ZR, Oteo J, Conejo C, et al. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing enterobacteriaceae in Spain. J Infect. 2016;72(2):152–160.
   PubMed Web of Science ®Google Scholar
• Tato M, Coque TM, Rucz-Garbajosa P, et al. Complex clonal and plasmid epidemiology in the first outbreak of enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis. 2007;45(9):1171–1178.
   PubMed Web of Science ®Google Scholar
• Ruiz-Garbajosa P, Curiao T, Tato M, et al. Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain. J Antimicrob Chemother. 2013;68(11):2487–2492.
   PubMed Web of Science ®Google Scholar
• Nori P, Szymczak W, Puius Y, et al. Emerging co-pathogens: New Delhi metallo-beta-lactamase producing enterobacterales infections in New York city COVID-19 patients. Int J Antimicrob Agents. 2020;56(6):106179.
   PubMed Web of Science ®Google Scholar
• Arcari G, Raponi G, Sacco F, et al. Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an italian hospital. Int J Antimicrob Agents. 2021;57(1):106245.
   PubMed Web of Science ®Google Scholar
• Gomez-Simmonds A, Annavajhala MK, McConville TH, et al. Carbapenemase-producing enterobacterales causing secondary infections during the COVID-19 crisis at a New York city hospital. J Antimicrob Chemother. 2020;76:380–384.
   Web of Science ®Google Scholar
• Montrucchio G, Corcione S, Sales G, et al. Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: keep an eye on the ball. J Glob Antimicrob Resist. 2020;23:398–400.
   PubMed Web of Science ®Google Scholar
• Farfour E, Lecuru M, Dortet L, et al. Carbapenemase-producing enterobacterales outbreak: another dark side of COVID-19. Am J Infect Control. 2020;48(12):1533–1536.
   PubMed Web of Science ®Google Scholar
• García-Meniño I, Forcelledo L, Rosete Y, et al. Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: the storm after the storm. J Infect Public Health. 2021;14(1):50–52.
   PubMed Web of Science ®Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332.
   PubMed Web of Science ®Google Scholar
• Dudoignon E, Caméléna F, Deniau B, et al. Bacterial pneumonia in COVID-19 critically ill patients: a case series. Clin Infect Dis. 2020;72:905–906.
   Web of Science ®Google Scholar
• Russo A, Falcone M, Gutiérrez-Gutiérrez B, et al. Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing enterobacteriaceae. Int J Antimicrob Agents. 2018;52(5):577–585.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22(7):707–710.
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definition conference. Crit Care Med. 2003;31:1250–1256.
   PubMed Web of Science ®Google Scholar
• Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Gutiérrez B, Salamanca E, De Cueto M, et al. A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing enterobacteriaceae. Mayo Clin Proc. 2016;91(10):1362–1371.
   PubMed Web of Science ®Google Scholar
• Cantón R, Gijón D, Ruiz-Garbajosa P. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic. Curr Opin Crit Care. 2020;26(5):433–441.
   PubMed Web of Science ®Google Scholar
• Porretta AD, Baggiani A, Arzilli G, et al. Increased risk of acquisition of new Delhi metallo-beta-lactamase-producing carbapenem-resistant enterobacterales (NDM-CRE) among a cohort of COVID-19 patients in a teaching hospital in Tuscany, Italy. Pathogens. 2020;9:E365.
   PubMed Web of Science ®Google Scholar
• Liu P, Li X, Luo M, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. Microb Drug Resist. 2018;24(2):190–198.
   PubMed Web of Science ®Google Scholar
• Tiri B, Sensi E, Marsiliani V, et al. Antimicrobial stewardship program, COVID-19, and infection control: spread of carbapenem-resistant Klebsiella pneumoniae colonization in ICU COVID-19 patients. What did not work? J Clin Med. 2020;9:2744.
   Web of Science ®Google Scholar
• Bork JT, Leekha S, Claeys K, et al. Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019. Infect Control Hosp Epidemiol. 2020. DOI:https://doi.org/10.1017/ice.2020.1360
   Google Scholar
• Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of COVID-19 in New York city. N Engl J Med. 2020;382(24):2372–2374.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):2052–2059.
   PubMed Web of Science ®Google Scholar
• Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study. Lancet. 2020;395(10239):1763–1770.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, et al. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing enterobacteriaceae. Clin Microbiol Rev. 2018;31(2):e00079–17.
   PubMed Web of Science ®Google Scholar
• Agyeman AA, Bergen PJ, Rao GG, et al. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents. 2020;55(1):105833.
   PubMed Web of Science ®Google Scholar
• Bardi T, Pintado V, Gómez-Rojo M, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis. 2021;40(3):495–502.
   PubMed Web of Science ®Google Scholar